CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Testing for SARS CoV2 Antigen and Antibodydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05607147
NCT05607147N/ACompleted

Rutgers Pilot for Pragmatic Return to Effective Dental Infection Control Through Triage and Testing (PREDICT)- Dental Health Care Workers

Rutgers, The State University of New Jersey·interventional·Posted Nov 7, 2022·Updated Aug 24, 2023

In Brief

A clinical study evaluating Testing for SARS CoV2 Antigen and Antibody for SARS-CoV2 Infection. Completed, enrolled 10 participants across 1 site.

Detailed Summary

10 asymptomatic DHCWs in the Oral Medicine clinic, Rutgers School of Dental Medicine, with no history of documented COVID-19 infection or viral exposure, were enrolled in a study that interrogated DHCWs' perceptions of safety and adoption of risk mitigation behavior. Following a baseline survey, finger-prick blood samples were collected twice two weeks apart using an innovative microsampling technique that replaces the need for venipuncture. Samples were processed using an in-house ELISA assay to detect IgM and IgG directed against the Receptor Binding Domain (RBD) of the Spike protein. Weekly Rapid Antigen testing of nasal swab specimens was used to document Antigen negativity during the study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedNov 7, 2022
Enrollment StartJan 26, 2021
Primary CompletionFeb 11, 2021
TodayJul 2, 2026
Enrollment to primary: 15 daysPosted 3.7 years ago

Interventions

Testing for SARS CoV2 Antigen and Antibodydevice

Antigen testing: Rapid Antigen testing (Point-of-care) Antibody testing: ELISA testing of microsampling 'finger-prick' specimen DHCW Survey for adoption of risk mitigation practices and for perceptions of safety